Human Nuclear Genome Transfer (So-Called Mitochondrial Replacement): Clearing the Underbrush

Area of Science:

• Bioethics
• Genetics
• Reproductive Technologies

Background:

• Mitochondrial diseases stem from mutations in mitochondrial DNA (mtDNA).
• Novel genetic strategies aim to prevent the transmission of mutated mitochondria.
• Human nuclear genome transfer is proposed as a method to prevent mitochondrial disease inheritance.

Purpose of the Study:

• To critically evaluate the purported therapeutic 'need' for human nuclear genome transfer.
• To analyze the ethical and social justice implications of this technology.
• To question the defense of human nuclear genome transfer and propose alternative resource allocation.

Main Methods:

• Review of basic information on mitochondrial disease and genetic prevention strategies.
• Analysis of contemporary debates surrounding mitochondrial replacement.
• Critique of the concept of 'need' versus 'want' in reproductive technologies.

Main Results:

• There is no compelling therapeutic need for human nuclear genome transfer.
• The technology is driven by 'wants' of patients and researchers.
• The term 'mitochondrial replacement' may be inaccurate, and ethical considerations are complex.

Conclusions:

• Limited resources should prioritize the common good over acquired desires.
• Social justice considerations should guide the development and application of reproductive technologies.
• Alternative approaches to mitochondrial disease prevention may be more ethically sound and socially responsible.